Supplemental material
Expert Review of Vaccines
Volume 23, 2024 - Issue 1
Open access
1,073
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
Stephen I. Peltona Chobanian and Avedisian School of Medicine, Boston University, Boston, MA, USAView further author information
, Joaquin F. Mould-Quevedob Global Medical Affairs, Seqirus USA Inc, Summit, NJ, USACorrespondence[email protected]
View further author information
& View further author information
Van Hung Nguyenc Global Health Economics and Epidemiology, VHN Consulting Inc, Montreal, CanadaView further author information
Pages 82-87
|
Received 03 Nov 2023, Accepted 11 Dec 2023, Published online: 14 Dec 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.